AstraZeneca Net Income TTM:
5.668B for March 31, 2013AstraZeneca Historical Net Income TTM Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | 5.668B |
| Dec. 31, 2012 | 6.282B |
| Sept. 30, 2012 | 6.247B |
| June 30, 2012 | 8.199B |
| March 31, 2012 | 8.701B |
| Dec. 31, 2011 | 9.983B |
| Sept. 30, 2011 | 10.12B |
| June 30, 2011 | 8.189B |
| March 31, 2011 | 8.183B |
| Dec. 31, 2010 | 8.053B |
| Sept. 30, 2010 | 7.985B |
| June 30, 2010 | 8.552B |
| March 31, 2010 | 8.152B |
| Dec. 31, 2009 | 7.521B |
| Sept. 30, 2009 | 7.216B |
| June 30, 2009 | 6.831B |
| March 31, 2009 | 6.744B |
| Dec. 31, 2008 | 6.101B |
| Sept. 30, 2008 | 6.119B |
| June 30, 2008 | 5.732B |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
| Sept. 30, 2003 | Go Pro |
| June 30, 2003 | Go Pro |
| March 31, 2003 | Go Pro |
| Dec. 31, 2002 | Go Pro |
| Sept. 30, 2002 | Go Pro |
| June 30, 2002 | Go Pro |
| March 31, 2002 | Go Pro |
| Dec. 31, 2001 | Go Pro |
| Sept. 30, 2001 | Go Pro |
| June 30, 2001 | Go Pro |
| March 31, 2001 | Go Pro |
| Dec. 31, 2000 | Go Pro |
About Net Income (TTM)
AZN Net Income TTM Benchmarks
| Companies | |
|---|---|
| GlaxoSmithKline | 6.620B |
| Pfizer | 15.53B |
| Merck | 6.022B |
AZN Net Income TTM Rankings
| Overall |
99th percentile 63 of 7593 |
| Sector |
99th percentile 6 of 650 in Healthcare |
| Industry |
88th percentile 6 of 52 in Drug Manufacturers - Major |
AZN Net Income TTM Range, Past 5 Years
| Minimum | 5.668B | Mar 2013 |
| Maximum | 10.12B | Sep 2011 |
| Average | 7.529B |
